MUMBAI, India, Jan. 8 -- Intellectual Property India has published a patent application (202511102576 A) filed by Graphic Era, Dehradun, Uttarakhand, on Oct. 24, 2025, for 'a process for biomanufacturing of personalized regenerative medicine therapies.'
Inventor(s) include Pallavi Singh.
The application for the patent was published on Dec. 12, under issue no. 50/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to an automated biomanufacturing process for producing patient-specific regenerative medicine therapies. The process integrates sequential modules, including patient sample acquisition (101), stem cell isolation (102), reprogramming (103), tissue scaffold integration (104), bioreactor-based culture (105), quality control (106), and clinical delivery (107). This standardized approach combines biosensing and automation for precise control over growth parameters, ensuring reproducible, safe, and clinically compliant regenerative medicine products for personalized therapeutic applications."
Disclaimer: Curated by HT Syndication.
